about
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosisβ2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study.Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism.Activated protein C inhibits neutrophil migration in allergic asthma: a randomised trial.A successful afternoon's struggle inserting a pacemaker.The influence of corticosteroids on hemostasis in healthy subjects.Can sodium excretion from single fasting morning urine really be used for estimation of dietary sodium intake?Prothrombotic state in patients with severe and prednisolone-dependent asthma.Loss of asthma control and activation of coagulation and fibrinolysis.Interferon-induced epithelial response to rhinovirus-16 in asthma relates to inflammation and FEVAnti-IL5 in Mild Asthma Alters Rhinovirus-Induced Macrophage, B Cell and Neutrophil Responses (MATERIAL): A Placebo-Controlled, Double-Blind StudyRisk of deep vein thrombosis and pulmonary embolism in asthmaAllergic burden and the risk of venous thromboembolismEffect of C1-inhibitor in adults with mild asthma: A randomized controlled trialCorticosteroid Withdrawal-Induced Loss of Control in Mild to Moderate Asthma Is Independent of Classic Granulocyte ActivationRectal Organoids Enable Personalized Treatment of Cystic FibrosisHome videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and coughEosinophils capture viruses, a capacity that is defective in asthma
P50
Q28276595-85FC5697-1F6E-48D7-BCFA-141E9EEA3A7FQ36089262-7D0468EC-FF90-4F9B-91EF-D7952AFDE98CQ36273274-BD08542E-1D00-439C-9F20-C3520FEB85DCQ37580170-31FA7105-336A-4E9F-89FF-439D4DD0DC2AQ38719920-50FC07CA-6254-4C22-A42A-E0E2ADC3EA60Q40898098-12BF1FA2-327D-4AF5-AC57-9D979B5686D6Q40993904-E9DC2355-224A-40F2-BA7A-1A803755E4FAQ42101337-321E556F-66F1-40EE-BBD4-6B3B0B3DB3E2Q48257684-A37BDB78-D3E8-41F5-AC58-297A40C7C79DQ51313143-A17735DF-4076-48AA-95AE-F5B081CC10E3Q51561430-26C06718-F432-4836-A34D-87778C6335BBQ51579648-782ED136-83FC-43A1-BCA3-FEF944CDD1CCQ57184841-D27D7A96-10CB-4CEC-8D31-367844A7ADA8Q59353124-764FAE2A-938D-4393-AE42-01F383043FAEQ85758764-F7A97295-0868-4A7E-B4BE-F09B590CD6EFQ86069791-1F344400-586E-4472-8529-2EC69D15CF8BQ90174208-E063979B-6818-4CBC-AC07-CEF681873F6CQ90771607-4904FFDB-C759-4F86-BC88-156019248338Q91548132-36161DF6-3B7C-41C3-8D8C-9B8DFE06C399Q92493458-B8BC8014-7339-4959-83E0-FB84373DFC85Q92751812-B7C307BB-1D2F-4EEF-8AA6-6483E9CC4F2E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Christof J Majoor
@en
Christof J Majoor
@nl
type
label
Christof J Majoor
@en
Christof J Majoor
@nl
prefLabel
Christof J Majoor
@en
Christof J Majoor
@nl
P31
P496
0000-0003-2677-9684